MVision, from Siemens Medical Solutions, is a volumetric in-line target imaging solution and the natural next step in Image Guided Radiation Therapy (IGRT). Designed to work with Siemens' linear accelerators, the system is the first commercial implementation of cone-beam technology utilizing a standard radiotherapy treatment beam. MVision makes it possible for the megavoltage (MV) source used for treatment to also create a 3-D image of the patient, enabling clinicians to "see inside" the patient at the most appropriate moment.
MVision fully integrates and automates all processes, including acquisition, reconstruction, registration, assessment, patient positioning and clinical review. With a few steps, therapists can calculate 3-D offsets, send them to the treatment couch to compensate for daily variations and safely deliver therapy.
MVision does not require an independent imaging source for IGRT, thus maximizing clinical accessibility and patient comfort. This innovation also frees caregivers from performing unnecessary electromechanical maintenance, so they can focus on versatile and efficient patient care.

Related Content

News | Radiation Oncology

August 27, 2021 — For decades, the National Comprehensive Cancer Network (NCCN) recommended forgoing post-lumpectomy ...

Time August 27, 2021
arrow
News | Radiation Therapy

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
News | Radiation Therapy

April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time April 16, 2020
arrow
News | Image Guided Radiation Therapy (IGRT)

February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive ...

Time February 11, 2020
arrow
News | Radiology Imaging

December 12, 2019 — Philips and the Regional Medical Center (RMC) announced a strategic 5-year partnership agreement ...

Time December 12, 2019
arrow
News | Radiation Therapy

October 22, 2019 — The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) ...

Time October 22, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac System at Dana-Farber/Brigham and Women's Cancer Center. The MRIdian provides for the delivery of radiation therapy to targeted tumors while simultaneously providing continuous magnetic resonance imaging (MRI).

Time October 08, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.

Time September 16, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

ViewRay Inc. announced that the company's MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation therapy systems will be featured at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-19 in Chicago. The meeting will feature a number of presentations highlighting the capabilities, clinical experience and patient outcomes with ViewRay's MRIdian and MRIdian Linac.

Time September 11, 2019
arrow
News | Radiation Therapy

Radiation dosimetry company announced plans to exhibit its full range of radiation therapy dosimetry solutions for acceptance, commissioning, beam data acquisition and patient-specific quality assurance (QA) at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-19 in Chicago.

Time August 27, 2019
arrow
Subscribe Now